New members join HPM board

HPM is pleased to announce that two new members, Gerd Kassel and Ernest Loumaye have joined the board.

Dr Kassel (top photo) is the VP pharmacovigilance at Takeda Global Research and Development in Europe and US. Dr Loumaye is the CEO and co-founder of PregLem SA, a biopharmaceutical company in Geneva.

The two new members bring with them many years of scientific and business experience in the pharmaceutical industry. HPM stands to gain from their knowledge of drug safety and their insights on long-term business strategies.

The other board members are Philippe Meier, Kerstin Karbe-Lauener and Pierre-André Lauener. For more information on HPM board members please visit Our Board section.

29 September 2008